Try our beta test site
438 studies found for:    "Venous Thromboembolism"
Show Display Options
Rank Status Study
21 Unknown  ICU Venous Thromboembolism Incidence Study in a Chinese Population
Condition: Venous Thromboembolism
Intervention:
22 Active, not recruiting Optimal Prophylactic Method of Venous Thromboembolism (VTE)
Condition: Venous Thromboembolism
Intervention: Drug: low molecular weight heparin
23 Recruiting Computerized Registry of Patients With Venous Thromboembolism (RIETE)
Condition: Venous Thromboembolism
Intervention:
24 Completed Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Recommended VTE pharmacological treatments according to international guidelines
25 Active, not recruiting Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant
Condition: Venous Thromboembolism
Intervention:
26 Withdrawn Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)
Condition: Venous Thromboembolism
Intervention: Drug: GW813893
27 Completed Reproducibility of Plasma Nucleosomes and Free DNA as Markers for Venous Thromboembolism
Condition: Venous Thromboembolism
Intervention:
28 Completed Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU Patients
Condition: Venous Thromboembolism
Interventions: Drug: Enoxaparin;   Drug: Bemiparin
29 Not yet recruiting Detecting Circulating Emboli in Patients With Acute Venous Thromboembolism
Condition: Venous Thromboembolism
Intervention: Device: Photoacoustic flow cytometry device
30 Not yet recruiting Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer
Condition: Venous Thromboembolism
Interventions: Drug: Apixaban;   Drug: Dalteparin
31 Recruiting Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Europe
Condition: Venous Thromboembolism
Intervention: Drug: Edoxaban
32 Completed Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery
Condition: Venous Thromboembolism
Interventions: Drug: Semuloparin sodium;   Drug: Placebo (for Enoxaparin sodium);   Drug: Enoxaparin sodium;   Drug: Placebo (for Semuloparin sodium)
33 Terminated Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer Resection
Condition: Venous Thromboembolism
Intervention: Other: blood tests
34 Unknown  Effectiveness And Safety of LMWH Treatment in Cancer Patients Diagnosed With Non-High Risk Venous Thromboembolism
Condition: Venous Thromboembolism
Intervention:
35 Not yet recruiting Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN)
Condition: Venous Thromboembolism
Intervention: Drug: Edoxaban
36 Recruiting StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study
Condition: Venous Thromboembolism
Intervention: Drug: Rosuvastatin
37 Withdrawn Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical Patients
Condition: Venous Thromboembolism
Interventions: Biological: heparin sodium - Blausiegel;   Biological: Heparin sodium - APP
38 Completed
Has Results
BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery
Condition: Venous Thromboembolism
Interventions: Drug: Enoxaparin;   Drug: BIBR 1048
39 Unknown  Efficacy of Sodium Heparin for Prophylaxis of Venous Thromboembolism in Surgical Patients
Condition: Venous Thromboembolism
Interventions: Biological: heparin sodium - Hipolabor;   Biological: Heparin sodium - APP
40 Recruiting ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTE
Condition: Venous Thromboembolism
Intervention: Drug: ELIQUIS (APIXABAN)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.